You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK – MGI Tech said on Monday that it has received the CE-IVD mark for the DNBSEQ-T7, DNBSEQ-G400, and DNBSEQ-G50 instruments, as well as regulatory approval for its G-Series sequencers in several countries in the Asia-Pacific region.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.
Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.